n a move that may spark another tussle with the pharmaceutical industry, the Chilean health minister has endorsed the idea of allowing the government to grant compulsory licenses for hepatitis C treatments, a step that was actively sought by lawmakers and patient advocates.

This comes in response to concern over rising prices, an issue that has prompted other cash-strapped governments to consider licenses in order to cover escalating costs. In Chile, the market price for Sovaldi, a Gilead Sciences (GILD) medicine that was the first in a new generation of treatments, is about $36,000 per patient, according to patient advocates.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • In Italy patients are allowed to purchase Sofosbuvir tablets For personal use only (not For resale) from abroad at far cheaper prices.In India thé price per box is less than $300 (you need 3 boxes For a treatment). Thé product is manufactured in India under a licence of thé patent holder.It is also manufactured in other countries.It would seem That, in Egypt, The industrial cost of a full treatment is around $280!!!!!! Hands.Vico

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.